AirNexis Gets $200M to Test China-Derived COPD Drug
AirNexis, a Palo Alto biotech, announced a $200 million financing round to launch clinical testing of a chronic obstructive pulmonary disease (COPD) therapy derived from Chinese research. The capital, sourced from a mix of U.S. and Chinese investors, will fund Phase 2/3 trials and scale manufacturing capabilities. The partnership exemplifies a growing China‑to‑U.S. model where Chinese drug assets are advanced by American startups. If successful, the drug could become a first‑in‑class treatment for a disease affecting millions worldwide.
Cellares and City of Hope Sign Deal to Automate Solid Tumor CAR T Cell Therapy Manufacturing
Biotech firm Cellares and cancer research center City of Hope have entered a partnership to evaluate Cellares’ automated Cell Shuttle manufacturing platform and Cell Q quality‑control system for City of Hope’s investigational CARpool IL13RA2‑EGFR CAR‑T therapy targeting glioblastoma multiforme. The...
Speculation Builds About a Deal for Revolution Medicines
Speculation is mounting that Revolution Medicines, a mid‑stage biotech focused on precision oncology, is in advanced talks with one or more large pharmaceutical companies. Media outlets report that the discussions could lead to a takeover or strategic partnership, though no...
Enliven’s Phase 1 Leukemia Pill Data Look Competitive with Novartis and Terns
Enliven Therapeutics announced Phase 1 results for its oral leukemia candidate, showing response rates and safety comparable to leading therapies from Novartis and Terns. The data revealed a 45% overall remission rate and manageable adverse events across 30 patients. The...
Viking Gets Commercial Chief While Other Obesity Biotechs Sell; Novo's Uli Stilz Steps Down
Viking Therapeutics announced the appointment of Neil Aubuchon as its chief commercial officer, signaling a push to accelerate commercialization of its obesity and MASH drug candidates. The move comes as the company’s shareholders grow impatient for a strategic partner or...
Evaluating Sarcopenia Criteria for Fall Prediction in Seniors
A recent cohort study examined multiple sarcopenia diagnostic criteria to determine which best predicts falls among seniors aged 65 and older. Researchers compared the European Working Group on Sarcopenia in Older People (EWGSOP2) algorithm, the SARC‑F questionnaire, and simple performance...
Mapping Prenatal Microbial Diversity in Amniotic Fluid
A new study has produced the first comprehensive map of microbial diversity in amniotic fluid, challenging the long‑held belief that the intrauterine environment is sterile. Researchers analyzed over 500 samples using ultra‑sensitive metagenomic sequencing, identifying a low‑biomass but distinct bacterial...
Gene Editing Pioneers Launch First Startup Focused on Custom CRISPR Therapies
A team of leading gene‑editing scientists has launched a new startup dedicated to developing custom CRISPR therapies for individual patients. The company builds on a landmark case last spring where researchers engineered a bespoke CRISPR treatment to correct a rare...
A New CRISPR Startup Is Betting Regulators Will Ease up on Gene-Editing
A new CRISPR startup, Aurora Therapeutics, aims to secure regulatory approval for a single, modular gene‑editing platform that can be tweaked for multiple mutations. Backed by $16 million from Menlo Ventures and advised by CRISPR co‑inventor Jennifer Doudna, Aurora’s first target...
Report Says MSD Is in Talks to Buy Revolution Meds
Financial Times reports MSD is in advanced talks to acquire Revolution Medicines in a deal valued between $28 billion and $32 billion, potentially the largest pharma merger since Pfizer's Seagen purchase. The announcement sent Revolution’s shares up 16% in pre‑market trading, giving...
Study Finds Food Waste Compost Less Effective than Potting Mix Alone
Researchers at the University of Arkansas evaluated food‑waste compost as a growing substrate for tomato and watermelon seedlings. The study, published in HortTechnology, found that pure food‑waste compost performed worse than standard peat‑based potting mix, while blends containing less than...
Bone Marrow Immune Cell Map Boosts Survival, Relapse Prediction in Multiple Myeloma
Researchers created a single‑cell immune atlas of bone‑marrow cells from 337 newly diagnosed multiple myeloma patients, profiling nearly 1.4 million plasma and immune cells. The study, published in Nature Cancer, links specific immune cell populations and signaling pathways to rapid relapse...
New Single‑Cell Testing Measures How Effectively Antibiotics Kill Bacteria
Researchers at the University of Basel introduced Antimicrobial Single‑Cell Testing (ASCT), a high‑throughput live‑cell imaging platform that quantifies antibiotic killing at single‑cell resolution. By dispensing bacteria into 1,536‑well plates and tracking up to one million images per experiment, the team...
M Ventures: Pharma CVC and Biotech Innovation in 2026
Merck KGaA’s corporate venture arm, M Ventures, opened 2026 with Managing Director Hakan Goker outlining its 2025 successes and 2026 priorities. The CVC highlighted marquee investments such as FoRx Therapeutics and Artios, which earned an FDA Fast Track designation, and...
Higher Consumption of Food Preservatives Is Associated with an Increased Risk of Type 2 Diabetes
Researchers from Inserm and partner institutions analyzed data from over 100,000 French adults in the NutriNet‑Santé cohort and found that higher consumption of food preservatives—both non‑antioxidant and antioxidant types—was linked to a 40‑49% increased incidence of type 2 diabetes. The study...
R-Loops Drive RNAPII Reprogramming in Early Development
A new study reveals that R‑loops, three‑strand nucleic‑acid structures, actively reprogram RNA polymerase II (RNAPII) positioning during early embryonic development. Genome‑wide mapping in mouse zygotes shows that 30% of RNAPII peaks coincide with R‑loop sites, directing transcription toward lineage‑specific genes....
Youth Sarcopenia and Body Composition via Bioimpedance
A new study published on Bioengineer.org reveals that bioimpedance analysis (BIA) can reliably detect sarcopenia and altered body composition in adolescents. Researchers evaluated over 1,200 youths aged 12‑19, finding a 7.4% prevalence of low muscle mass that exceeds prior estimates...
CircRNA14781 Drives Olaparib Resistance in Ovarian Cancer
Researchers identified circular RNA circRNA14781 as a key driver of olaparib resistance in high‑grade ovarian cancer. The non‑coding RNA is markedly overexpressed in tumor samples that fail PARP‑inhibitor therapy and functions by sponging tumor‑suppressive microRNAs, thereby re‑activating DNA‑repair pathways. In...
Mapping Eucalyptus Genes for Phosphate Transport Efficiency
Researchers have completed a high‑resolution map of eucalyptus genes that control phosphate transport, pinpointing dozens of candidate transporters. Expression profiling shows several genes surge when trees face low‑phosphate soils, suggesting natural efficiency mechanisms. The team demonstrated CRISPR‑mediated edits that boost...
Chlorella Nanogels Suppress Lung Injury Inflammation
Researchers have engineered chlorella‑derived nanogels that markedly suppress inflammation in experimental lung injury. In murine models, the nanogels lowered pro‑inflammatory cytokines, reduced alveolar edema, and improved survival rates. The delivery platform leverages the natural biocompatibility of chlorella polysaccharides to target...
2025 FDA Approvals: Innovation Holds Steady in First Year Under New Leadership
Under the FDA’s new leadership, 2025 saw the approval of 46 new molecular entities and 10 new biologics, matching the pace of recent years. The agency’s review process remained on schedule, suggesting that the transition in senior management has not...
Albendazole’s Impact on Helminths in Yunnan Kids
Researchers evaluated a school‑based albendazole deworming program among 3,200 children aged 5‑12 in Yunnan province. Baseline surveys showed a 42% helminth infection rate, which fell to 13% after a single annual dose. The intervention also correlated with modest gains in...
OpenAI Brings ChatGPT to Hospitals on the Heels of Launching Consumer Health Tool
OpenAI unveiled ChatGPT for Healthcare, extending its popular conversational AI into hospitals and health systems. The offering follows the recent launch of a consumer‑focused health tool, signaling a broader push into clinical environments. OpenAI says the service will integrate with...
Expert Consensus on Validating Internal Jugular Ultrasound Tool
A panel of leading emergency physicians, intensivists, and radiologists released an expert consensus outlining a structured validation pathway for internal jugular vein ultrasound (IJU) tools. The framework delineates three validation phases—technical performance, operator reproducibility, and clinical outcome impact—backed by specific...
Evaluating Acupuncture for Cancer Treatment Fatigue: A Review
A recent systematic review examined acupuncture as a therapeutic option for cancer‑related fatigue, analyzing data from 18 randomized controlled trials involving over 2,000 patients. The analysis found that acupuncture produced modest but statistically significant reductions in fatigue severity compared with...
New Framework Enhances Climate Health Vulnerability Analysis
A multidisciplinary research team has unveiled a new analytical framework that fuses high‑resolution climate data with population health metrics to assess climate‑related health vulnerability. The platform leverages machine‑learning‑driven spatial modeling, incorporating temperature, air‑quality, and socioeconomic indicators to predict disease risk...
Microbial Communities and Tight Junctions in Cattle’s Gut
A new study links specific microbial communities to the integrity of tight junction proteins in the bovine gut, showing that a higher abundance of *Ruminococcus* and *Lactobacillus* correlates with stronger barrier function. Metagenomic sequencing and intestinal tissue analysis revealed a...
Deformable Adjuvants Can Enhance Immune Activation in New Vaccine Design
Researchers at the Chinese Academy of Sciences have engineered aluminum‑stabilized Pickering emulsions (ASPE) that act as deformable adjuvants, providing mechanical cues to dendritic cells. By adjusting nanoparticle crystallinity, the interfacial stiffness can be tuned to activate the mechanosensitive PIEZO1 channel,...
Aberrant Calcium Signaling and Neuronal Activity in the L271H CACNA1D (Cav1.3) iPSC Model of Neurodevelopmental Disease
Researchers created the first patient‑derived iPSC model carrying the de novo L271H CACNA1D (Ca_v1.3) variant linked to neurodevelopmental disease. The study shows that Ca_v1.3 is the dominant L‑type calcium channel in neural progenitor cells, where the mutation drives heightened spontaneous calcium...
TIGIT Disruption Boosts Low-Avidity T Cell Tumor Attack
Researchers have demonstrated that genetic disruption of the inhibitory receptor TIGIT markedly amplifies the anti‑tumor activity of low‑avidity T cells. In mouse models, TIGIT‑deficient T cells infiltrated tumors more efficiently and induced significant tumor regression, especially when paired with existing...
WRKY Gene Family’s Role in Cucurbita Moschata Resistance
Researchers have identified specific WRKY transcription factors that enhance disease resistance in Cucurbita moschata, commonly known as winter squash. Using genome‑wide association studies and CRISPR‑mediated knock‑outs, the team pinpointed WRKY45 and WRKY70 as key regulators against Phytophthora blight. Field trials...
Noncanonical TRPM4 Controls Intestinal Fluid Balance
Researchers have identified a noncanonical isoform of the TRPM4 ion channel that directly regulates intestinal fluid secretion and absorption. Using mouse models and human intestinal organoids, the study showed that loss of this isoform leads to dysregulated electrolyte transport and...
METTL3 Loss Drives Glioma via Macrophage Lipids
Researchers have discovered that loss of the RNA methyltransferase METTL3 accelerates glioma progression by reprogramming macrophage lipid metabolism. The study shows METTL3‑deficient tumor cells induce lipid accumulation in tumor‑associated macrophages, creating an immunosuppressive microenvironment that fuels tumor growth. Mechanistic analysis...
Designing Liver Simulants with Hyperelastic Micromechanics
On January 9, 2026 Bioengineer.org published a suite of research highlights spanning nanomedicine, parasitology, medical imaging, climate‑health analytics, and plant genetics. The pieces report that chlorella‑based nanogels markedly suppress lung injury inflammation, albendazole effectively reduces helminth burdens in Yunnan children, and an...
Sanofi Calls Rejection of Potential MS Blockbuster 'Unexpected'
Sanofi announced that the FDA rejected its experimental multiple‑sclerosis therapy, labeling the decision unexpected. The agency raised substantive questions late in the review process, leaving insufficient time for Sanofi to amend its submission. The setback threatens the anticipated launch of...
Illumina Hires Eric Green as Chief Medical Officer
Illumina announced the appointment of Eric Green, former director of the National Human Genome Research Institute and a pioneering geneticist, as its new chief medical officer. Green will lead the company’s clinical strategy, regulatory affairs, and diagnostic product development. The...
How Light Reflects on Leaves May Help Researchers Identify Dying Forests
Researchers at the University of Notre Dame have demonstrated that leaf spectral reflectance measured from airborne or satellite sensors can predict the expression of key stress‑related genes. By sampling sugar maple and red maple leaves in Wisconsin and Michigan, they...
Stem Cell-Derived Neurons Navigate to Form Connections in the Injured Brain
Researchers at Sanford Burnham Prebys and Duke‑NUS have demonstrated that human embryonic stem cell‑derived cortical neurons can be grafted directly into the lesion cavity of mice after ischemic stroke, survive, mature into NeuN‑positive neurons, and re‑establish long‑range connections. By tracing...
Science Spotlight: Thwarting Melanoma Immune Evasion
Researchers have uncovered new molecular pathways that melanoma cells use to dodge immune surveillance, focusing on PD‑L1 up‑regulation and downstream signaling. A high‑throughput CRISPR‑Cas9 screen pinpointed several previously unknown evasion genes, enabling a targeted combination‑therapy approach. Early‑phase trials combining checkpoint...
FDA Staff Cuts Mostly Didn't Impact New Drug Review Timelines, Analysis Finds
Despite thousands of staff cuts, retirements, and leadership departures at the FDA in 2025, the agency’s drug reviewers largely maintained their review schedules. An internal analysis shows that median approval times for new molecular entities shifted by less than one...
New Lilly Data Suggest Zepbound Boosted Effect of Autoimmune Drug
Eli Lilly’s Phase 3b trial shows its weight‑loss blockbuster Zepbound (tirzepatide) can amplify the efficacy of an existing autoimmune therapy in a targeted patient cohort. The combination yielded superior clinical endpoints compared with the autoimmune drug alone, suggesting a synergistic...
Secretive Rampart Bioscience Closes After Pursuing Non-Viral Gene Therapy
Rampart Bioscience, a stealth biotech founded less than 15 months ago with a $125 million Series A, announced its closure after failing to advance its non‑viral gene‑therapy platform. The company had aimed to address delivery challenges that have limited viral vectors, but...
MoonLake Revives FDA Push; Biotech Trio to Debut in Hong Kong
MoonLake Immunotherapeutics has re‑filed its FDA application for a novel therapy targeting a rare dermatological disorder, aiming to overcome earlier regulatory setbacks. The company highlighted new clinical data showing a 45% improvement in lesion clearance among trial participants. Simultaneously, three...
Rapid Sterility Test Considerations
Rapid sterility testing (RST) is reshaping pharmaceutical quality control by cutting release times to roughly six days and providing objective, non‑visual detection methods. Nelson Labs highlights its ATP bioluminescence platform, which requires product‑specific validation, expanded organism panels, and interference studies...
FDA Drug and Biologic Approvals List 2025: Sign-Offs Dip During Agency Upheaval
The FDA’s 2025 drug and biologic approval tally fell sharply amid a year of internal upheaval. Approvals dropped about 15% compared with 2024, reflecting slower review times as thousands of staff departed and senior leadership changed. The agency’s operational instability...
HHS Loses Bid to Suspend Court Block on 340B Rebate Pilot
The U.S. Department of Health and Human Services (HHS) failed to overturn a federal court order that barred the launch of its 340B rebate pilot. A three‑judge panel of the U.S. Court of Appeals affirmed the lower‑court injunction, keeping the...
Tessera Trimming 90 Employees as Part of Pipeline Prioritization
A wave of workforce reductions swept the biotech sector in early 2024, with Tessera Therapeutics cutting 90 employees (about 35% of its staff) to prioritize its AATD and sickle‑cell programs after a $275 million Regeneron partnership. Similar cuts hit companies ranging...
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag
Vanda Pharmaceuticals’ sleep‑aid Hetlioz was again rejected by the FDA for a jet‑lag indication, despite the agency acknowledging positive efficacy in trials. The regulator objected to Vanda’s reliance on phase‑advance protocols, deeming them insufficiently representative of real‑world travel conditions. The...
Deregulating the Rapidly Evolving Digital Health Industry
The article examines how governments are loosening regulations to accommodate the fast‑moving digital health sector, especially AI‑driven diagnostics and telemedicine. Recent policy proposals aim to streamline FDA approvals, expand data‑sharing frameworks, and create sandboxes for experimental AI tools. OpenAI’s latest...
Charles River CEO Jim Foster to Retire; Samsung Bio Buys a GSK Factory
Charles River Laboratories announced that CEO James C. Foster will retire on May 5 after more than a decade at the helm, and the board has named longtime COO Dr. Laura Miller as his successor. The transition comes as the company seeks...